ACTL9 is a sperm-specific actin-related protein that builds the subacrosomal cytoskeletal architecture required for acrosome-nucleus attachment during spermiogenesis (PMID:35616329). It assembles with ACTRT1, ACTRT2, and ACTL7A into a multimeric complex in the subacrosomal region of spermatids, and disruption of this complex—as occurs in ACTRT1 deficiency—reduces ACTL9 expression and causes its ectopic redistribution, mislocalizing the acrosome relative to the nucleus (PMID:35616329, PMID:38414365). ACTL9 additionally interacts with the perinuclear theca protein CABS1, and a truncating CABS1 mutation that weakens this interaction is accompanied by acrosome loss and aberrant PLCζ localization in sperm (PMID:40407971). ACTL9 is a phosphorylation substrate of the testis-specific kinase TSSK3 (PMID:36306217). Beyond its role in acrosome anchoring, ACTL9 is required for normal sperm flagellar ultrastructure: homozygous mutations cause irregular mitochondrial sheath arrangement and '9+2' axoneme defects with reduced motility, recapitulated in knock-in mice, and loss-of-function and missense variants are causative for male infertility and total fertilization failure (PMID:38963606, PMID:38769899).